Immunologic Characteristics of CATCH 22 Syndrome |
Hye Young Ryu1, Eun Kyung Jo2, Eun Jung Cheon3, Hong Ryang Kil1, Jae Ho Lee1 |
1Department of Pediatrics, College of Medicine, Chungnam National University, Taejon, Korea 2Department of Microbiology, College of Medicine, Chungnam National University, Taejon, Korea 3Department of Pediatrics, Eulji Medical College, Taejon, Korea |
CATCH 22 증후군의 면역학적 특성 |
유혜영1, 조은경2, 천은정3, 길홍량1, 이재호1 |
1충남대학교 의과대학 소아과학교실 2충남대학교 의과대학 미생물학교실 3을지의과대학 소아과학교실 |
|
|
Abstract |
Purpose : Microdeletion of chromosome 22q11.2 are associated with DiGeorge syndrome(DGS), velocardiofacial syndrome(VCFS) and conotruncal anomaly face syndrome(CTAFS). DGS was originally described as an immunodeficiency disorder secondary to impaired T cell production due to thymic aplasia or hypoplasia. But the frequency & severity of immunodeficiency of other clinical syndromes associated with the chromosome 22q11 deletion has not been investigated. This study was undertaken to investigate the frequency and severity of immunodeficiency, the relationship of the immunodeficiency to clinical phenotypes, and the change of immunologic status with age in CATCH 22 syndromes patients.
Methods : Sixteen patients with CATCH 22 syndrome with characteristic clinical phenotype and chromosome 22q11 deletion were studied. Humoral and cellular immunities were examined by measuring serum IgG, IgA, IgM level and by T cell subset through flow cytometry and lymphocyte proliferation test by common T cell mitogens respectively.
Results : 69% of patients with CATCH 22 syndrome were found to have evidence of immunocompromise. The severity of the immunodeficiency did not correlate with any particular phenotypic features nor was it restricted to patients who were categorized as having DiGeorge syndrome. The severity of immunodeficiency tended to be normalized with age.
Conclusion : The presence of the immunocompromise is common and its severity cannot be predicted based on the clinical phenotype of CATCH 22 syndrome. Therefore, each child with CATCH 22 syndromes regardless of clinical phenotype should be extensively assessed for earlier detection of subclinical immunodeficiency. |
Key Words:
CATCH 22, Immunodeficiency, T cells, Velocardiofacial syndrome |
|